Development and validation of a predictive nomogram for osteoporosis in patients with psoriasis
Open Access
- 10 July 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1826823
Abstract
Background: Psoriasis is a chronic inflammatory disease associated with increased risk of osteoporosis. However, practical tools for identifying high-risk patients in clinical settings remain limited. This study aimed to develop and validate a nomogram for predicting osteoporosis in patients with psoriasis. Methods: A retrospective cohort study was conducted including 639 psoriasis patients from January 2023 to October 2025. Patients were randomly divided into training ( n = 447) and validation ( n = 192) sets at a 7:3 ratio. Osteoporosis was defined as dual-energy X-ray absorptiometry (DXA) T -score ≤−2.5. Univariate analysis and multivariate logistic regression were performed to identify independent risk factors. A nomogram was constructed based on the final model and evaluated using C-index, calibration curves, and decision curve analysis (DCA). Results: The overall prevalence of osteoporosis was 11.7% (75/639). Six independent risk factors were identified: advanced age (OR = 4.054, 95%CI 2.281–7.237), disease duration (OR = 1.068, 95%CI 1.026–1.11), psoriatic arthritis (OR = 2.178, 95%CI 1.243–3.796), vitamin D deficiency (OR = 5.148, 95%CI 1.986–17.672), systemic corticosteroid use (OR = 3.501, 95%CI 1.756–6.826), male sex (OR = 0.399, 95%CI 0.229–0.686). The nomogram demonstrated good discrimination with AUC of 0.824 in the training set and 0.771 in the validation set. Calibration curves showed excellent agreement between predicted and observed probabilities. DCA confirmed the clinical utility of the model. Conclusion: We developed and validated a practical nomogram incorporating psoriasis-specific and traditional risk factors for predicting osteoporosis risk. This tool may facilitate early identification of high-risk patients and guide clinical decision-making for DXA screening and preventive interventions.Keywords
This publication has 29 references indexed in Scilit:
- Systemic Psoriasis: From Molecular Mechanisms to Global Management StrategiesClinical Reviews in Allergy & Immunology, 2025
- Type D personality and social inhibition: drivers of cardiovascular risk and reduced physical activity in psoriatic arthritisClinical Rheumatology, 2025
- Vitamin D and human health: evidence from Mendelian randomization studiesEuropean Journal of Epidemiology, 2024
- Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis planOsteoporosis International, 2022
- Association of Potent and Very Potent Topical Corticosteroids and the Risk of Osteoporosis and Major Osteoporotic FracturesJAMA Dermatology, 2021
- Osteoporosis y psoriasisActas Dermo-Sifiliograficas, 2019
- Glucocorticoid-induced osteoporosis: an updateEndocrine, 2018
- Quantitative and Qualitative Changes of Bone in Psoriasis and Psoriatic Arthritis PatientsJournal of Bone and Mineral Research, 2015
- Bone mineral density and bone turnover in patients with psoriatic arthritisClinical Rheumatology, 2007
- An estimate of the worldwide prevalence and disability associated with osteoporotic fracturesOsteoporosis International, 2006